Home > Journals > Minerva Endocrinologica > Past Issues > Minerva Endocrinologica 2007 December;32(4) > Minerva Endocrinologica 2007 December;32(4):263-73

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA ENDOCRINOLOGICA

A Journal on Endocrine System Diseases


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,118


eTOC

 

REVIEWS  


Minerva Endocrinologica 2007 December;32(4):263-73

language: English

Cardiovascular risk in women with polycystic ovary syndrome

Cho L. W., Atkin S. L.

Department of Medicine University of Hull, Hull, UK


PDF  


Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women that has received an immense amount of attention in the recent years due to the possible associated risk of cardiovascular disease. Women with PCOS demonstrate an adverse cardiovascular profile characteristic of the cardiometabolic syndrome and an established risk of progression to type 2 diabetes. Despite the presence of cardiovascular risk factors and increased surrogate markers of cardiovascular disease, it is unclear if they develop accelerated atherosclerosis. This article summarized the recent development and findings of cardiovascular risk in women with PCOS, and finally the therapeutic options will be discussed.

top of page

Publication History

Cite this article as

Corresponding author e-mail